Belite Bio CMO Hendrik Scholl Sells 10,000 ADS Shares on June 16, 2026

Hendrik Peter Scholl, Chief Medical Officer of Belite Bio, Inc. (BLTE), filed a Form 4 disclosing the sale of 10,000 American Depositary Shares (ADS) on June 16, 2026. The sales occurred through eight separate transactions at weighted average prices ranging from $137.6053 to $145.0212 per share, with total proceeds exceeding $1.4 million. Following these transactions, Scholl's indirect ownership through Bioptima Ltd. decreased from 35,000 ADS to 25,000 ADS. Each ADS represents one ordinary share of the company. The sales were executed at various price points throughout the trading day, with the highest transaction price at $145.0212 and the lowest at $137.6053. This filing represents routine insider trading activity by a corporate officer.